CES1 and prostate cancer: Research [50] found that melatonin effectively inhibits lipid accumulation in prostate cancer cells by regulating the epigenetic aspects of CES1. This process enhances endoplasmic reticulum stress, promotes apoptosis, and reduces androgen synthesis, thereby preventing the progression and metastasis of prostate cancer.